Risk of Foot Ulcer and Lower-Extremity Amputation Among Participants in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study

Overview

Journal Diabetes Care

Specialty Endocrinology

Date 2022 Jan 10

PMID 35007329

Authors

Edward J Boyko

Leila R Zelnick

Barbara H Braffett

Rodica Pop-Busui

Catherine C Cowie

Gayle M Lorenzi

Rose Gubitosi-Klug

Bernard Zinman

Ian H de Boer

Affiliations

Soon will be listed here.

Abstract

Objective: Intensive glycemic control reduces the risk of kidney, retinal, and neurologic complications in type 1 diabetes (T1D), but whether it reduces the risk of lower-extremity complications is unknown. We examined whether former intensive versus conventional glycemic control among Diabetes Control and Complications Trial (DCCT) participants with T1D reduced the long-term risk of diabetic foot ulcers (DFUs) and lower-extremity amputations (LEAs) in the subsequent Epidemiology of Diabetes Interventions and Complications (EDIC) study.

Research Design And Methods: DCCT participants (n = 1,441) completed 6.5 years on average of intensive versus conventional diabetes treatment, after which 1,408 were enrolled in EDIC and followed annually over 23 years for DFU and LEA occurrences by physical examination. Multivariable Cox proportional hazard regression models estimated associations of DCCT treatment assignment and time-updated exposures with DFU or LEA.

Results: Intensive versus conventional glycemic control was associated with a significant risk reduction for all DFUs (hazard ratio 0.77 [95% CI 0.60, 0.97]) and a similar magnitude but nonsignificant risk reduction for first-recorded DFUs (0.78 [0.59, 1.03]) and first LEAs (0.70 [0.36, 1.36]). In adjusted Cox models, clinical neuropathy, lower sural nerve conduction velocity, and cardiovascular autonomic neuropathy were associated with higher DFU risk; estimated glomerular filtration rate <60 mL/min/1.73 m2, albuminuria, and macular edema with higher LEA risk; and any retinopathy and greater time-weighted mean DCCT/EDIC HbA1c with higher risk of both outcomes (P < 0.05).

Conclusions: Early intensive glycemic control decreases long-term DFU risk, the most important antecedent in the causal pathway to LEA.

Citing Articles

The Prevalence, Aetiology and Healing Trajectories of Hard-To-Heal Wounds in South Africa.

Idensohn P, Gilbert K, Boodhoo K, Howard K, van de Vyver M Int Wound J. 2025; 22(3):e70155.

PMID: 40068966 PMC: 11896689. DOI: 10.1111/iwj.70155.

Evaluating and mapping the evidence that screening for diabetic foot disease meets the criteria for population-wide screening: a scoping review.

Pallin J, Connell L, McIntosh C, Kavanagh P, Dinneen S, Kearney P BMJ Public Health. 2025; 2(1):e000561.

PMID: 40018213 PMC: 11812814. DOI: 10.1136/bmjph-2023-000561.

Analysis of risk factors for foot ulcers in diabetes patients with neurovascular complications.

Fan Z, Liu Y, Xie H, Yang Q, Zhang G, Zhang P BMC Public Health. 2025; 25(1):792.

PMID: 40011841 PMC: 11866585. DOI: 10.1186/s12889-025-21639-1.

Wound management, healing, and early prosthetic rehabilitation: Part 1 - A scoping review of healing and non-healing definitions.

Williams-Reid H, Johannesson A, Buis A Can Prosthet Orthot J. 2025; 7(2):43715.

PMID: 39990241 PMC: 11844765. DOI: 10.33137/cpoj.v7i2.43715.

Impact of ozone concentration on the treatment effectiveness of diabetic foot syndrome: a pilot single-centre study.

Pasek J, Szajkowski S, Rokicka D, Wrobel M, Travagli V, Cieslar G Postepy Dermatol Alergol. 2025; 41(6):626-633.

PMID: 39877112 PMC: 11770577. DOI: 10.5114/ada.2024.145477.

References

Nathan D, Genuth S, Lachin J, Cleary P, Crofford O, Davis M . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14):977-86. DOI: 10.1056/NEJM199309303291401. View

Goldman M, Clark C, Craven T, Davis R, Williams T, Velazquez-Ramirez G . Effect of Intensive Glycemic Control on Risk of Lower Extremity Amputation. J Am Coll Surg. 2018; 227(6):596-604. DOI: 10.1016/j.jamcollsurg.2018.09.021. View

Nathan D . The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care. 2013; 37(1):9-16. PMC: 3867999. DOI: 10.2337/dc13-2112. View

Younes N, Cleary P, Steffes M, de Boer I, Molitch M, Rutledge B . Comparison of urinary albumin-creatinine ratio and albumin excretion rate in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study. Clin J Am Soc Nephrol. 2010; 5(7):1235-42. PMC: 2893069. DOI: 10.2215/CJN.07901109. View

Carter R, Lackland D, Cleary P, Yim E, Lopes-Virella M, Gilbert G . Intensive treatment of diabetes is associated with a reduced rate of peripheral arterial calcification in the diabetes control and complications trial. Diabetes Care. 2007; 30(10):2646-8. PMC: 2655324. DOI: 10.2337/dc07-0517. View

van Schie C, Vermigli C, Carrington A, Boulton A . Muscle weakness and foot deformities in diabetes: relationship to neuropathy and foot ulceration in caucasian diabetic men. Diabetes Care. 2004; 27(7):1668-73. DOI: 10.2337/diacare.27.7.1668. View

Hurley L, Kelly L, Garrow A, Glynn L, Mcintosh C, Alvarez-Iglesias A . A prospective study of risk factors for foot ulceration: the West of Ireland Diabetes Foot Study. QJM. 2013; 106(12):1103-10. DOI: 10.1093/qjmed/hct182. View

Boyko E, Ahroni J, Stensel V, Forsberg R, Davignon D, Smith D . A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care. 1999; 22(7):1036-42. DOI: 10.2337/diacare.22.7.1036. View

Miller R, Secrest A, Ellis D, Becker D, Orchard T . Changing impact of modifiable risk factors on the incidence of major outcomes of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care. 2013; 36(12):3999-4006. PMC: 3836155. DOI: 10.2337/dc13-1142. View

10.

Pecoraro R, Reiber G, BURGESS E . Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care. 1990; 13(5):513-21. DOI: 10.2337/diacare.13.5.513. View

11.

Young M, Adams J, Anderson G, Boulton A, Cavanagh P . Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects. Diabetologia. 1993; 36(7):615-21. DOI: 10.1007/BF00404070. View

12.

Steffes M, Cleary P, Goldstein D, Little R, Wiedmeyer H, Rohlfing C . Hemoglobin A1c measurements over nearly two decades: sustaining comparable values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study. Clin Chem. 2005; 51(4):753-8. PMC: 2635091. DOI: 10.1373/clinchem.2004.042143. View

13.

. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care. 1999; 22(1):99-111. PMC: 2745938. DOI: 10.2337/diacare.22.1.99. View

14.

Armstrong D, Boulton A, Bus S . Diabetic Foot Ulcers and Their Recurrence. N Engl J Med. 2017; 376(24):2367-2375. DOI: 10.1056/NEJMra1615439. View

15.

Abbott C, Carrington A, ASHE H, Bath S, Every L, Griffiths J . The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med. 2002; 19(5):377-84. DOI: 10.1046/j.1464-5491.2002.00698.x. View

16.

FRIEDEWALD W, Levy R, Fredrickson D . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502. View

17.

Boyko E, Ahroni J, Cohen V, Nelson K, Heagerty P . Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle Diabetic Foot Study. Diabetes Care. 2006; 29(6):1202-7. DOI: 10.2337/dc05-2031. View

18.

Costacou T, Orchard T . Recent trends over time in vascular disease in type 1 diabetes: insights from the Pittsburgh Epidemiology of Diabetes Complications study. Cardiovasc Endocrinol Metab. 2019; 8(1):3-13. PMC: 6739893. DOI: 10.1097/XCE.0000000000000164. View

19.

Pop-Busui R, Low P, Waberski B, Martin C, Albers J, Feldman E . Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC). Circulation. 2009; 119(22):2886-93. PMC: 2757005. DOI: 10.1161/CIRCULATIONAHA.108.837369. View

20.

Leese G, Feng Z, Leese R, Dibben C, Emslie-Smith A . Impact of health-care accessibility and social deprivation on diabetes related foot disease. Diabet Med. 2013; 30(4):484-90. DOI: 10.1111/dme.12108. View